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Summary.-The haematological responses of BDF1 mice were monitored after i.v.
or i.p. inoculation of L1210 leukaemic cells. Although a marked decrease in haemato-
crit was observed in mice given L1210 by either route, the anaemia was most pro-
nounced after the i.p. route. The leucocyte count was more markedly increased after
i.v. inoculation than after i.p. inoculation. The number ofplatelets decreased following
either route, but was more depressed by i.v. inoculation. When mice were treated
with VM-26 on Day 4 after i.p. inoculation of 106 L1210 cells, the haematological
responses were altered. VM-26 prevented the accumulation of haemorrhagic ascites
fluid and the precipitous decline in haemotacrit. However, the number of leucocytes
increased dramatically, most significantly during the 48 h before death. VM-26
caused a temporary restoration of platelet count to near baseline levels. By the time
of death, however, a second decrease in platelets had occurred. The results suggest
that the haematological response of mice to L1210 leukaemic cells varies according
to the route of inoculation, and that these tumour-induced haematological responses
of the host can be modified by treatment with VM-26.
HAEMATOLOGICAL CHANGES ofill-defined
aetiology follow the inoculation of mice
with transplantable tumours (Law et al.,
1.949; Harriss & Hoelzer, 1974) and are
frequently associated with human neo-
plasia (Kremer & Laszlo, 1973). Dys-
crasias may be capable of altering the
therapeutic index of oncolytic drugs that
as a group generally depress haemo-
poiesis (Laszlo & Kremer, 1973).
BDF1 mice inoculated with either
L1210 or L5178Y ascites tumour cells, or
with diffusion chambers containing L1210
cells, rapidly developed thrombocyto-
penia (Hacker et al., 1977). Within 24 h of
i.p. inoculation of these transplantable
tumours, the platelet count decreased and
continued to do so until the count was less
than 20% of normal. The platelet count
remained depressed until death.
The present study further examines the
haematological response of mice to trans-
plantable tumour lines, and reports a
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tumour-induced decrease in haematocrit
after inoculation of L1210 cells. Changes
in the haematocrit ratios and platelet
counts in mice after inoculation of L1210
and treatment with VM-266 (4'demethyl-
epipodophyllotoxin 9-(4,6-0-2-thenylidine-
B-D-glucopyranoside; NSC-122819) are
then related to drug-induced changes in
the leucocyte counts and to the course of
the leukaemia.
MATERIALS AND METHODS
Animals-.Female C57BL6 x DBA/2 mice
(hereafter referred to as BDF1) from Jackson
Laboratories, Bar Harbor, Maine, weighing
- 20 g, were housed in the central animal
facilities with uniform humidity, temperature
and photoperiod. Food and water were
supplied ad libitum.
Tumour cells.-The L1210 leukaemia was
maintained in the ascites form by weekly
passage in DBA/2 mice. For experimentation,
cells were diluted to the desired concentrationM. HACKER, D. ROBERTS AND C. W. JACKSON
with Earle's basal salt solution and given
either i.v. via the tail vein or i.p. to BDF,
mice.
Drug preparation.-VM-26 (16 mg) was
dissolved in 0 1 ml of dimethyl sulphoxide;
subsequently, and in sequence, 1 ml of
Tween 80R and 8 9 ml of 0.90o NaCl were
added. This drug preparation was diluted
with a similarly prepared vehicle to permit
i.p. injection of various doses in a volume of
0 01 ml/g body wt.
Haematological measurerments.-Blood Awas
obtained from the retro-orbital sinus using
heparinized capillary tubes (Clay-Adams,
Parsippany, N.J.). Twenty ,ul of blood for
platelet and leucocyte determinations were
removed from the capillary tube and placed
in a Unopette (Becton-Dickson, Rutherford,
N.J.) containing 1-98 ml of 1% ammonium
oxalate. Platelets were counted under phase
microscopy by the method of Brecher &
Cronkite (1950). Total number of nucleated
blood cells, hereafter referred to as leuco-
cytes, were counted in the manner described
by Wintrobe et al. (1974). The remainder of
the blood in each capillary tube was centri-
fuged for determination of the PCV (Win-
trobe et al., 1974). Specimens of blood were
obtained on alternate days from mice to
avoid haematological depression from samp-
ling.
RESULTS
Mice inoculated with 106 L1210 ascites
tumour cells i.p. lived an average of
7-2 + 0-6 days and died with an accumula-
tion of haemorrhagic ascites fluid con-
taining tumour cells. Increasing numbers
oferythrocytes were seen in the peritoneal
cavity from Day 3. The mean life span of
mice given 106 L1210 cells i.v. was 5-5 + 0 5
days. No haemorrhagic ascites fluid was
seen in mice after i.v. inoculation.
The time of onset in the depression of
the haematocrit was related to the number
of L1210 cells inoculated i.p. (Fig. la).
Regardless of the number of cells inocu-
lated, however, animals died shortly after
the haematocrit decreased to -015. The
rate of decrease in haematocrit was pro-
portional to the number of cells inoculated
(Fig. lb). Regression equations for the
rate of depression intersect at 16 h,
regardless of inoculum size. This inter-
section suggests that the various inocula
began to depress the haematocrit simul-
taneously, but several days elapsed before
a significant decrease was observed.
The i.v. route of inoculation of L1210
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FIG. Ia. Depression of the PCV after inocu-
lation of various numbers of L1210 cells.
Mice were inoculated i.p. with 103-106
L1210 cells, and the PCV was measured
on alternate days. The mean + s.d. are
indicated for 5 mice. (b) Changes ofPCV in
L1210-inoculated mice. On the abscissa is
indicated the PCV for control mice minus
the PCV of mice after inoculation of L121 0
cells.
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FiG. 2. Depression of the PCV by i.p. andl
iv. inoculation with 106 L1210 cells. Values
represent mean + s.d. for 5 mice.
cells also lowered the haematocrit (Fig. 2),
but 4 days elapsed before the haematocrit
was decreased significantly. By Day 5,
when the first tumour-related deaths
occurred, the haematocrit was similar to
that after i.p. inoculation, and was about
two-thirds of the control value. Mice died
with a higher haematocrit after i.v.
inoculation than after i.p. inoculation.
Although haemorrhage into the peritoneal
cavity undoubtedly contributed to the
decreased haematocrit, the coincident fall
after i.v. inoculation without a con-
comitant accumulation of haemorrhagic
ascites fluid indicates that the peritoneal
haemorrhage was not the sole cause of the
depressed haematocrit.
The elevation ofWBC count was studied
as an index of systemic disease, and was
related to the route of tumour-cell inocu-
lation. After i.p. inoculation of 106 L1210
cells, the leucocyte count started to in-
crease between Days 2 and 3 (Fig. 3). By
Day 6, about one day before death, the
leucocyte count was 22 x 109/1 of blood.
The rate of leucocyte increase was dram-
atically different when the L1210 cells
were inoculated i.v. The leucocyte count
then began to increase between Days 2
and 3, and continued to increase to
85 x 109/1 of blood by Day 5. Regardless
of the route of inoculation, the increases
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FiG. 3.-Elevation of WBC count after i.p. or
iv. inoculation of 106 L1210 cells. Mean
+ s.d. for a group of 5 mice.
in the leucocyte count were accompanied
by the appearance of leukaemic lympho-
blasts.
The platelet count of mice decreased
after inoculation of L1210 cells by either
route (Fig. 4). After i.p. inoculation of 106
L1210 cells, the platelet count was signifi-
cantly decreased within 24 h ofinoculation
and continued to decrease until Day 3.
From Day 3 until Day 7, however, the
platelet count remained fairly stable at
0*45 x 106/mm3. When mice were inocu-
lated with 106 L1210 cells i.v., the de-
crease in platelet count was slightly
delayed compared to i.p. inoculation. By
death, however, thrombocytopenia was
greater after the i.v. route, with the final
platelet count being 0 1 x 106/mm3.
Thus, inoculation ofL1210 leukaemia cells
causes significant anaemia, leucocytosis
and thrombocytopenia. The route of
inoculation had a significant effect upon
the magnitude of these changes.
To assess the effect of drug therapy on
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tion of 106 L1210 cells. By delaying
therapy until Day 4, we were able to
monitor the haematological response of
the host both before and after VM-26
treatment. The mean lifespan of treated
animals was related to the dose ofVM-26,
and ranged from 86 + 0 5 days to 11*6 +
0 5 days. Preliminary studies indicated
that VM-26 given at these doses to non-
tumour-bearing mice had no effect upon
the haematological parameters of mice.
Drug treatment modified the tumour-
a INTRAVENOUS induced decrease in haematocrit (Fig. 5a).
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FIG. 5.-The effect of VM-26 on L1210-
induced changes in the haematological
parameters of BDF1 mice. Mice were
inoculated i.p. with 106 L1210 cells on Day
0. On Day 4, they were injected i.p. with
various doses of VM-26 from figure 5a.
Depression ofPCV. b. Leucocyte elevation.
c. Platelet-count depression. O
16 mg/kg; 0 O 10 mg/kg; v
6 mg/kg; *- control.
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decrease in haematocrit. Regardless of
dose, however, VM-26-treated mice died
with a haematocrit about twice the level
observed at death in untreated mice.
Furthermore, the accumulation ofhaemor-
rhagic ascites fluid in untreated mice given
L1210 cells i.p. was prevented by VM-26
treatment.
The elevation of leucocyte count in
tumour-bearing mice was delayed 2-4
days by drug treatment (Fig. 5b). The
delay before the number of leucocytes
increased was directly related to the dose
of VM-26. At death, the leucocyte count
inVM-26-treated mice was between 60 and
70 x 109/1, resembling that in mice inocu-
lated by the i.v. route.
By Day 4, the platelet count oftumour-
bearing mice was maximally depressed.
Within 24 h after VM-26 treatment, the
platelet count had started to recover
(Fig. 5c). The increase in platelet count
was directly related to the dose ofVM-26.
Regardless of VM-26 dose, however, the
platelet count began to decrease on Day 8,
and by death was less than in untreated
mice.
DISCUSSION
The present studies, aswell as the earlier
report (Hacker et al., 1977) indicate that
the haematological responses induced in
the host by L1210 tumour cells would
complicate many forms of oncolytic
chemotherapy. In particular, sensitivity
of the host to the toxicity of oncolytic
drugs should be increased by the thrombo-
cytopenia and anaemia induced by the
tumour. Similar tumour-induced haemato-
logical responses were reported earlier by
Harriss & Hoelzer (1974) after the inocu-
lation of rats with myelomonocytic leuk-
aemia L5222. Recently Jackson et al.
(1980) have presented evidence that the
thrombocytopenia induced by L1210 leu-
kaemia results primarily from shortened
platelet survival and organ pooling.
Although intra-abdominal haemorrhage
undoubtedly contributed to the depression
ofthe haematocrit after i.p. inoculation of
L1210, the haematocrit was also depressed
after i.v. inoculation. The rate of de-
pression of the haematocrit was related to
the number oftumour cells inoculated i.p.
However, when we assumed a doubling
time of 12 h for L1210 cells (Skipper et al.,
1965) the change in the haematocrit
correlated inversely with the calculated
number oftumour cells. Austin etat. (1979)
teported recently that the L1210 leuk-
aemia suppresses mouse erythroid colony
formation, which may in part explain the
anaemia in L1210-bearing mice.
The present studies confirm the report
by Skipper et al. (1965) that i.v. inocula-
tion of L1210 cells produced a higher
leucocyte count than a similar inoculum
injected i.p., and that i.v. inoculation is
not accompanied by the accumulation of
ascites associated with i.p. inoculation.
The haematocrit, leucocyte and platelet
changes associated with i.p. L1210 inocu-
lation were modified by delayed treatment
with VM-26, to mimic the changes after
i.v. inoculation. These results suggest that
VM-26 killed the peritoneal cells but had
a much less powerful effect on systemic
cells. Therefore, the progress ofthe disease
more closely resembled that after the i.v.
route of inoculation. Initially, VM-26
blockedthe expected decrease in haemato-
crit, and these values never decreased as
expected after i.p. inoculation. At death,
mice lacked the accumulation of bloody
ascites normally associated with i.p.
inoculation. Examination ofthe leucocyte
counts after treatment with VM-26 con-
firmed the suspected change in course of
the leukaemia; the increase in leucocyte
count more closely resembled the pattern
associated with i.v. inoculation than i.p.
inoculation. Although i.p. treatment with
VM-26 permitted a temporary recovery in
the platelet counts, these counts subse-
quently decreased before death to a level
belowthat associated withi.p. inoculation,
and were similar to the level associated
with i.v. inoculation. The potential signifi-
cance ofthese observations is thattumour-
induced haematological responses by the
host may be useful in monitoring the
effectiveness ofchemotherapy, in selecting
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subsequent treatment, and in confirming
the cause ofdeath after treatment of mice
inoculated with L1210 cells.
The present observations are of signifi-
cance in planning protocols for delayed
treatment of mice inoculated with L1210
ascites cells. The observations indicate
that protocols for delayed treatment of
L1210 cells should incorporate a chemo-
therapeutic phase, similar to induction
therapy for acute lymphoblastic leuk-
aemia in man, to reverse the thrombocyto-
penia and, if possible, the anaemia that is
induced by the transplantable tumour.
Although our data relate anaemia to the
number of tumour cells calculated to be
present, chemotherapy did not restore a
normal PCV. The reason for the failure to
recover a more normal PCV is unknown,
though a similar PCV pattern was seen
during spontaneous recovery of the plate-
let count after inoculation ofL5178Y cells
(Hacker et al., 1977). Our preliminary
studies with these doses of VM-26 did not
alter the haematocrit of tumour-bearing
animals. It is possible that there was
insufficient time between treatment and
subsequent progression of the disease to
allow recovery of the PCV by erythro-
poiesis.
The drug-induced changes in the leuco-
cyte count provide a simple method for
monitoring the response of leukaemia to
an anticancer drug. In the present studies,
all doses of VM-26 markedly reduced the
population of ascites tumour cells in mice
given L1210 cells i.p. On the other hand,
the peripheral-blood leucocyte count of
mice inoculated i.p.withL1210andtreated
with VM-26 subsequently increased into
the range observed after i.v. inoculation.
It is too early to know whether the leuco-
cyte count will predict generally for
relapse by systemically located cells. How-
ever, the present data do suggest that with
VM-26 treatment conversion of L1210
inoculated i.p. into the systemic form
associated with i.v. inoculation occurred.
This conversion of disease states could
lead to a 10-fold error in estimation of the
fraction of cells killed by an oncolytic
agent. This estimate is based on the fact
that i.v. inoculation reduced life-span by
about 2 days in comparison with an
equivalent number of tumour cells inocu-
lated i.p., a period of time that is about
equivalent to a 10-fold variation in the
number of cells inoculated i.p. (Skipper
et al., 1965).
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